Standard of Care Treatment Strategies

Managing SAPHO syndrome (or Adult Chronic Nonbacterial Osteitis) has historically been challenging because the disease affects both the bone and the skin ^[1]. However, a landmark international consensus reached in 2023–2024 has provided an expert-informed, stepwise roadmap for treatment, although many therapies are used off-label ^[2].

The goal of treatment is to “calm” the overactive immune response, stop the bone from remodeling abnormally, and clear the skin ^[3]. Because there is no single “cure,” doctors use a tiered approach, moving to the next level if the current one is not controlling the disease ^[2].

The Stepwise Treatment Guide

The international consensus recommends following this approach for active Adult CNO ^[2][4]:

Step 1: NSAIDs (4–12 Weeks)

The first line of defense is a high-dose NSAID (non-steroidal anti-inflammatory drug), such as naproxen or ibuprofen ^[2].

• The Goal: To reduce pain and initial inflammation.
• Safety Warning: High-dose NSAIDs carry gastrointestinal bleeding, kidney, and cardiovascular risks. Discuss your history of ulcers, kidney disease, blood pressure, and pregnancy with your doctor, and do not exceed the prescribed dose.
• Alternatives: If standard NSAIDs cause stomach issues, your doctor may switch you to a COX-2 inhibitor (like celecoxib), which is often gentler on the digestive tract but still carries kidney and cardiovascular risks ^[2].
• Timeline: If you do not see significant improvement within 4 to 12 weeks, the consensus recommends moving to Step 2 ^[2].

Step 2: Advanced Medical Therapy (3–12 Months)

If NSAIDs are not enough, doctors choose between two main types of advanced therapy. The choice often depends on whether your bone pain or your skin symptoms are more severe ^[4][5].

• Intravenous (IV) Bisphosphonates: These are often the preferred second-line choice for bone pain ^[2]. While usually used for osteoporosis, in SAPHO they help stop the painful “remodeling” of the bone ^[6].
  • Effect: They are highly effective for bone pain but often have limited effect on the skin ^[5].
  • Pre-check: You must have a dental exam and check your kidney function, calcium, and vitamin D levels before starting to avoid severe hypocalcemia ^[3].
• TNF Inhibitors (Biologics): Drugs like adalimumab or infliximab block a specific inflammatory protein ^[7].
  • Effect: These are excellent for both bone and joint inflammation ^[7].
  • Safety: Because they suppress the immune system, you need screening for tuberculosis (TB) and hepatitis B, vaccination planning, and an urgent action plan if you develop a fever.
  • Warning: In some patients, these can cause a “paradoxical flare,” where the skin symptoms actually get worse even as the bone pain gets better ^[5][8].

The Role of Conventional DMARDs

You may be familiar with “conventional” DMARDs (disease-modifying antirheumatic drugs) like methotrexate or sulfasalazine.

• Important Distinction: The 2023–2024 consensus does not routinely recommend these for Adult CNO (bone inflammation) itself ^[2].
• When they are used: They are reserved for patients who have an “overlap” condition—meaning they have SAPHO plus another diagnosis like psoriatic arthritis (PsA) or axial spondyloarthritis (axSpA) ^[2][9].

Why “Wait and See” Isn’t Enough

Treatment is monitored every 12 weeks through clinical exams and, ideally, MRI ^[3].

• Bone vs. Skin: It is common for your bones to feel better while your skin stays the same, or vice versa ^[5].
• Antibiotics: While sometimes used “off-label” if C. acnes is suspected, the international consensus does not currently include antibiotics in the standard treatment steps for sterile Adult CNO. However, confirmed bacterial osteomyelitis always requires appropriate antimicrobial evaluation and treatment ^[10][2].
• Surgery: Surgery is not a treatment for the inflammation itself ^[6]. It is strictly reserved for complications, such as a bone becoming so thickened that it presses on a nerve or a spine segment becoming unstable ^[11][12].

Once you reach “stable remission”—where your pain is gone and your MRI shows no active swelling—your doctor may consider “tapering” (slowly lowering) your doses rather than keeping you on high-dose medication indefinitely. Remember that relapse is possible, and any taper must be carefully planned with your clinician ^[3][2].